“Embracing scientists translate ideas into outcomes.”

…by providing the right tools for fast and effective research: meet the eyes^TM series.

Products

β-eye^TM

The most straightforward and agile preclinical scanner for live, whole-body mouse imaging of all PET radiopharmaceuticals.

γ-eye^TM

A unique preclinical scanner for dynamic, whole-body mouse imaging of SPECT radiopharmecauticals and Theranostic agents.

φ-eye^TM

A highly sensitive, benchtop, in vivo optical imaging system for fluorescence and bioluminescence imaging studies.

Phantoms

Our unique realistic mouse & rat phantoms for a wide range of imaging modalities.

Vital Signs monitoring

Our non-invasive, real-time monitoring platform, that improves welfare and can function as a standalone device.

Applications

Cardiac PET imaging using ¹⁸F-FDG

Cardiac PET imaging in a mouse model of myocardial infarction. Image info: 80 min post injection - 20 min scan - total injected dose 6 MBq

Applications

Ac-225 imaging using γ-eye™

In vivo imaging of alpha-emitting isotopes made possible, with BIOEMTECH technology. Two illustrative images, from two timepoints: 2h and 24h post injection with a Ac-225 radiopharmaceutical, in an oncology model. Image info: Scan duration 10 min. Dose injected: 3.5 μCi / 0.13 MBq. Images acquired at Radiomedix laboratories.

Applications

Using Zr-89 for lungs imaging

In vivo imaging of free Zr-89 accumulation in the lungs of a healthy mouse following intratracheal administration. Imaging parameters: 30 min post-administration static acquisition - injected activity 94.4 μCi - acquisition time 5min.

Applications

Tumor imaging using a bioluminescent dye

This study demonstrates the use of D-Luciferin as a bioluminescence reporter in a non-orthotopic glioblastoma tumor model. Imaging was performed at day 3 and 10 after the inoculation of 1 million U87MG-Luc2 cells. Key parameters: injected concentration of 3 mg, injection volume of 200 μL saline and exposure time of 5 minutes.

Applications

Evaluation and staging of Epidermoid Carcinoma

This case study highlights the use of fluorescence optical imaging for in vivo therapy evaluation and staging of Epidermoid Carcinoma (Squamous Cell Carcinoma) in preclinical models. RFP dyes were utilized to enable targeted imaging and enhance visualization of tumor dynamics.

SEE ALL APPLICATIONS